Page 277 - Read Online

Kim JW. The prognostic potential of keratin 18 in breast cancer 22. Carmeliet P. VEGF as a key mediator of angiogenesis in cancer.
associated with tumor dedifferentiation, and the loss of estrogen and Oncology 2005;69 Suppl 3:4-10.
progesterone receptors. Cancer Biomark 2011;10:219-31. 23. Gockel I, Schimanski CC, Heinrich C, Wehler T, Frerichs K,
17. Kabir NN, Rönnstrand L, Kazi JU. Keratin 19 expression correlates Drescher D, von Langsdorff C, Domeyer M, Biesterfeld S, Galle
with poor prognosis in breast cancer. Mol Biol Rep 2014;41:7729-35. PR, Junginger T, Moehler M. Expression of chemokine receptor
18. Mishra PJ, Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov CXCR4 in esophageal squamous cell and adenocarcinoma. BMC
JP, Ganesan S, Glod JW, Banerjee D. Carcinoma-associated Cancer 2006 18;6:290.
fibroblast-like differentiation of human mesenchymal stem cells. 24. Gros SJ, Graeff H, Drenckhan A, Kurschat N, Blessmann M,
Cancer Res 2008;68:4331-9. Rawnaq T, Izbicki JR. CXCR4/SDF1-alpha-mediated chemotaxis
19. McInroy L, Määttä A. Down-regulation of vimentin expression
inhibits carcinoma cell migration and adhesion. Biochem Biophys in an in vivo model of metastatic esophageal carcinoma. In Vivo
Res Commun 2007;360:109-14. 2012;26:711-8.
20. Gu ZD, Li JY, Li M, Gu J, Shi XT, Ke Y, Chen KN. Matrix 25. Salazar N, Muñoz D, Kallifatidis G, Singh RK, Jordà M, Lokeshwar
metalloproteinases expression correlates with survival in patients BL. The chemokine receptor CXCR7 interacts with EGFR to
with esophageal squamous cell carcinoma. Am J Gastroenterol promote breast cancer cell proliferation. Mol Cancer 2014;13:198.
2005;100:1835-43. 26. Velasco-Velázquez M, Jiao X, De La Fuente M, Pestell TG, Ertel A,
21. van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Lisanti MP, Pestell RG. CCR5 antagonist blocks metastasis of basal
Cell Mol Life Sci 2008;65:3756-88. breast cancer cells. Cancer Res 2012;72:3839-50.

Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ July 29, 2016 ¦ 267